Watanabe Keisuke 渡邊慶介

Researcher Number	60847466
Other IDs
Affiliation (Current)	2025: 国立研究開発法人国立がん研究センター, 研究所, 主任研究員
Affiliation (based on the past Project Information) *help	2020 – 2023: 国立研究開発法人国立がん研究センター, 研究所, 主任研究員
Review Section/Research Field	Principal Investigator Basic Section 54010:Hematology and medical oncology-related / Basic Section 50020:Tumor diagnostics and therapeutics-related Except Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords	Principal Investigator CART細胞療法 / CAR-T細胞 / T細胞性腫瘍 / 成人T細胞白血病 / キメラ抗原受容体 / T細胞性リンパ腫 / CART細胞 / モガムリズマブ / CCR4 / PTCL / CTCL / ATLL … More Except Principal Investigator … More 抗体医薬による輸注反応（IRR) / 抗体薬物複合体 / サイトカインプロファイル / 新規抗体医薬 / サイトカイン / IRR / がん新薬早期開発 Less

キメラ抗原受容体遺伝子改変T細胞免疫記憶の解明Principal Investigator
- Principal Investigator
  
  渡邊慶介
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  National Cancer Center Japan
進行癌に対する次世代抗体薬投与時サイトカインプロファイル緊急網羅的解析モデル探索
- Principal Investigator
  
  清水俊雄
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Wakayama Medical University
Chimeric antigen receptor T cell therapy for T cell malignanciesPrincipal Investigator
- Principal Investigator
  
  Watanabe Keisuke
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  National Cancer Center Japan

All 2023 2022 2021

All Journal Article Presentation

[Journal Article] Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma2023
- Author(s)
  Watanabe Keisuke、Gomez Angela M.、Kuramitsu Shunichiro、Siurala Mikko、Da Tong、Agarwal Sangya、Song Decheng、Scholler John、Rotolo Antonia、Posey Avery D.、Rook Alain H.、Haun Paul L.、Ruella Marco、Young Regina M.、June Carl H.
- Journal Title
  
  Blood Advances
  
  Volume: 7 Issue: 14 Pages: 3416-3430
- DOI
  10.1182/bloodadvances.2022008327
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K07848
[Journal Article] Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial)2023
- Author(s)
  Okuma Hitomi S.、Watanabe Keisuke、Tsuchihashi Kenji、Machida Ryunosuke、Sadachi Ryo、Hirakawa Akihiro、Ariyama Hiroshi、Kanai Masashi、Kamikura Masahisa、Anjo Kenta、Hiramitsu Akari、Sekine Shigeki、Okita Natsuko、Mano Hiroyuki、Nishikawa Hiroyoshi、Nakamura Kenichi、Yonemori Kan
- Journal Title
  
  Clinical Cancer Research
  
  Volume: 29 Issue: 24 Pages: 5079-5086
- DOI
  10.1158/1078-0432.ccr-23-1807
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K07848, KAKENHI-PROJECT-22H00455
[Journal Article] Engineering strategies for broad application of TCR-T- and CAR-T-cell therapies2021
- Author(s)
  Watanabe K, Nishikawa H
- Journal Title
  
  International Immunology
  
  Volume: 33 Issue: 11 Pages: 551-562
- DOI
  10.1093/intimm/dxab052
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17H06162, KAKENHI-PROJECT-20K16460
[Presentation] 腫瘍代謝環境を介した免疫細胞制御機構の解明と細胞療法への展開2022
- Author(s)
  渡邊慶介
- Organizer
  鶴岡カンファレンス2022
- Data Source
  KAKENHI-PROJECT-20K16460
[Presentation] CD19標的に続く新規CAR-T細胞療法の開発2022
- Author(s)
  渡邊慶介
- Organizer
  名古屋血液eセミナー
- Data Source
  KAKENHI-PROJECT-20K16460
[Presentation] CCR4を標的としたキメラ抗原受容体遺伝子改変T細胞療法の非臨床試験2022
- Author(s)
  渡邊慶介
- Organizer
  令和3年度HTLV-1関連疾患研究領域研究班合同発表会
- Data Source
  KAKENHI-PROJECT-20K16460
[Presentation] T細胞性腫瘍を標的としたCART細胞療法の開発2022
- Author(s)
  渡邊慶介
- Organizer
  第14回日本血液疾患免疫療法学会
- Data Source
  KAKENHI-PROJECT-20K16460
[Presentation] T細胞性腫瘍に対するCART細胞療法の開発2022
- Author(s)
  渡邊慶介
- Organizer
  第81回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-20K16460
[Presentation] 今後の免疫細胞療法2　CAR-T細胞療法を例にとって2022
- Author(s)
  渡邊慶介
- Organizer
  21世紀先端医療コンソーシアム
- Invited
- Data Source
  KAKENHI-PROJECT-20K16460

1. 清水俊雄 (30411599)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
2. 吉田達哉 (10729338)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. 小山隆文 (30828538)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 勝屋友幾 (40752704)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 山本昇 (80501874)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 洪泰浩 (80426519)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 寺倉精太郎 (40625141)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 西川博嘉

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Watanabe Keisuke 渡邊 慶介

Research Projects

Research Products

Co-Researchers

キメラ抗原受容体遺伝子改変T細胞免疫記憶の解明Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

進行癌に対する次世代抗体薬投与時サイトカインプロファイル緊急網羅的解析モデル探索

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Chimeric antigen receptor T cell therapy for T cell malignanciesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial)2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Engineering strategies for broad application of TCR-T- and CAR-T-cell therapies2021

Author(s)

Journal Title

DOI

Data Source

[Presentation] 腫瘍代謝環境を介した免疫細胞制御機構の解明と細胞療法への展開2022

Author(s)

Organizer

Data Source

[Presentation] CD19標的に続く新規CAR-T細胞療法の開発2022

Author(s)

Organizer

Data Source

[Presentation] CCR4を標的としたキメラ抗原受容体遺伝子改変T細胞療法の非臨床試験2022

Author(s)

Organizer

Data Source

[Presentation] T細胞性腫瘍を標的としたCART細胞療法の開発2022

Author(s)

Organizer

Data Source

[Presentation] T細胞性腫瘍に対するCART細胞療法の開発2022

Author(s)

Organizer

Data Source

[Presentation] 今後の免疫細胞療法2 CAR-T細胞療法を例にとって2022

Author(s)

Organizer

Data Source

Watanabe Keisuke 渡邊慶介

[Presentation] 今後の免疫細胞療法2　CAR-T細胞療法を例にとって2022